{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:52:44Z","timestamp":1791111164406,"version":"4.1.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"DOI":"10.1038\/s41433-026-04922-2","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:59:56Z","timestamp":1791050396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on: \u2018Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist\u2019"],"prefix":"10.1038","author":[{"given":"Eva M.","family":"del Amo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Mangas-Sanju\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7348-7337","authenticated-orcid":false,"given":"Anxo","family":"Fern\u00e1ndez-Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"4922_CR1","doi-asserted-by":"publisher","unstructured":"Ezzine S, Gale R, Bailey C, Patel PJ, Sivaprasad S, Keshk Z, et al. Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist. Eye. 2026. https:\/\/doi.org\/10.1038\/s41433-026-04540-y.","DOI":"10.1038\/s41433-026-04540-y"},{"key":"4922_CR2","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1167\/iovs.65.7.3154","volume":"65","author":"PK Kaiser","year":"2024","unstructured":"Kaiser PK, Turner KC, Bihorel S, Chiu J, Harnisch L, Chittenden J, et al. Population pharmacokinetic modeling and simulation of ocular clearance for aflibercept 8 mg and 2 mg and association with durability of effect [abstract]. Investig Ophthalmol Vis Sci. 2024;65:3154 https:\/\/doi.org\/10.1167\/iovs.65.7.3154.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4922_CR3","unstructured":"Birkett DJ. Pharmacokinetics made easy. 2nd ed. Sydney: McGraw-Hill Australia; 2010."},{"key":"4922_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/pharmaceutics11080365","volume":"11","author":"L Garcia-Quintanilla","year":"2019","unstructured":"Garcia-Quintanilla L, Luaces-Rodr\u00edguez A, Gil-Mart\u00ednez M, Mondelo-Garc\u00eda C, Maro\u00f1as O, Mangas-Sanju\u00e1n V, et al. Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration. Pharmaceutics. 2019;11:365.","journal-title":"Pharmaceutics."},{"key":"4922_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1023\/A:1014414520282","volume":"28","author":"DE Mager","year":"2001","unstructured":"Mager DE, Jusko WJ. General pharmacokinetic model for drugs exhibiting target-mediated drug disposition. J Pharmacokinet Pharmacodyn. 2001;28:507\u201332.","journal-title":"J Pharmacokinet Pharmacodyn"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04922-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:01:31Z","timestamp":1791108091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04922-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":5,"alternative-id":["4922"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04922-2","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}